CoronaVac induces lower neutralising activity against variants of concern than natural infection

Lancet Infect Dis. 2021 Oct;21(10):1352-1354. doi: 10.1016/S1473-3099(21)00568-5. Epub 2021 Aug 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / blood
  • Antibodies, Neutralizing / immunology*
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • COVID-19 / blood*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage*
  • China
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • Thailand

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Immunoglobulin G